Buying guide
Apollo RT6 vs XPENG Robotaxi in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
| Attribute | No image on file | No image on file |
|---|---|---|
| Manufacturer | Baidu | XPeng Robotics |
| Form factor | av | av |
| Maturity | commercial | research |
| Availability | internal-onlyenterprise | internal-onlyenterprise |
| Price | Not announced | Not announced |
| Capability claims | — | — |
| Brain |
|
|
| Verified deployments | 6 | 0 |
| Privacy practices | 8capture-indicator, location-tracking, location-tracking, third-party-sharing, data-retention, training-data-use, data-deletion-control, third-party-sharing | 7location-tracking, biometric-storage, third-party-sharing, data-retention, cloud-upload, data-deletion-control, data-sale |
| Sources on file | 37 | 6 |
Editorial summaries
Apollo RT6
Baidu's Apollo RT6 is the company's sixth-generation autonomous robotaxi: a purpose-built battery-electric vehicle (a cross between an SUV and a minivan, with a detachable steering wheel) on Baidu's Apollo Galaxy / Xinghe self-driving platform, powering the Apollo Go fully-driverless commercial ride-hailing service across Chinese cities and some international markets. There is no consumer price: it is a robotaxi service vehicle, not sold to consumers. Baidu manufactures it without relying on a third-party automaker at roughly 204,600 RMB (about $28,600) per vehicle, about half the cost of the prior generation: a verified per-vehicle build cost (from Baidu's disclosures), not a consumer price. It is one of the Chinese commercial-at-scale anchors of the robotaxi cluster.
XPENG Robotaxi
XPENG's robotaxi line comprises three models (reported 5-, 6-, and 7-seater variants) announced at XPENG AI Day on November 5, 2025, powered by the same vision-centric VLA 2.0 model that drives XPENG's IRON humanoid and its ADAS systems. There is no consumer price: it is a pre-commercial robotaxi program, not a vehicle sold to consumers. The verified-vs-claimed point is on maturity: trial operation is expected in 2026 (with mapping and navigation company Amap named as an early partner), so the program is pre-commercial and recorded at research maturity under DEPLOY's ladder, pending real-world trial operation. It continues the Chinese-robotaxi tier of the cluster (alongside Baidu Apollo, Pony AI, WeRide, Didi), distinguished by its vision-only / vision-centric approach and a shared VLA 2.0 brain across robotaxi, humanoid, and ADAS.
Machine-readable: this page as markdown.